Literature DB >> 31123840

Macrophages in Systemic Sclerosis: Novel Insights and Therapeutic Implications.

Diana M Toledo1, Patricia A Pioli2.   

Abstract

PURPOSE OF REVIEW: Macrophages play key roles in tissue homeostasis and immune surveillance, mobilizing immune activation in response to microbial invasion and promoting wound healing to repair damaged tissue. However, failure to resolve macrophage activation can lead to chronic inflammation and fibrosis, and ultimately to pathology. Activated macrophages have been implicated in the pathogenesis of systemic sclerosis (SSc), although the triggers that induce immune activation in SSc and the signaling pathways that underlie aberrant macrophage activation remain unknown. RECENT
FINDINGS: Macrophages are implicated in fibrotic activation in SSc. Targeted therapeutic interventions directed against SSc macrophages may ameliorate inflammation and fibrosis. While current studies have begun to elucidate the role of macrophages in disease initiation and progression, further work is needed to address macrophage subset heterogeneity within and among SSc end-target tissues to determine the disparate functions mediated by these subsets and to identify additional targets for therapeutic intervention.

Entities:  

Keywords:  Fibrosis; Innate immunity; Macrophages; Monocytes; Scleroderma; Systemic sclerosis

Year:  2019        PMID: 31123840     DOI: 10.1007/s11926-019-0831-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  67 in total

Review 1.  The chemokine system in diverse forms of macrophage activation and polarization.

Authors:  Alberto Mantovani; Antonio Sica; Silvano Sozzani; Paola Allavena; Annunciata Vecchi; Massimo Locati
Journal:  Trends Immunol       Date:  2004-12       Impact factor: 16.687

2.  HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway.

Authors:  Ramunas M Vabulas; Parviz Ahmad-Nejad; Sanghamitra Ghose; Carsten J Kirschning; Rolf D Issels; Hermann Wagner
Journal:  J Biol Chem       Date:  2002-02-12       Impact factor: 5.157

3.  Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.

Authors:  Erin Morris; Izabela Chrobak; Andreea Bujor; Faye Hant; Christine Mummery; Peter Ten Dijke; Maria Trojanowska
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

4.  Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.

Authors:  Susan K Mathai; Mridu Gulati; Xueyan Peng; Thomas R Russell; Albert C Shaw; Ami N Rubinowitz; Lynne A Murray; Jonathan M Siner; Danielle E Antin-Ozerkis; Ruth R Montgomery; Ronald A S Reilkoff; Richard J Bucala; Erica L Herzog
Journal:  Lab Invest       Date:  2010-04-19       Impact factor: 5.662

5.  The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.

Authors:  Yoshihito Shima; Yusuke Kuwahara; Hiroyuki Murota; Shun Kitaba; Mari Kawai; Toru Hirano; Junsuke Arimitsu; Masashi Narazaki; Keisuke Hagihara; Atsushi Ogata; Ichiro Katayama; Ichiro Kawase; Tadamitsu Kishimoto; Toshio Tanaka
Journal:  Rheumatology (Oxford)       Date:  2010-09-05       Impact factor: 7.580

6.  Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.

Authors:  Nobuyo Higashi-Kuwata; Masatoshi Jinnin; Takamitsu Makino; Satoshi Fukushima; Yuji Inoue; Faith C Muchemwa; Yuji Yonemura; Yoshihiro Komohara; Motohiro Takeya; Hiroaki Mitsuya; Hironobu Ihn
Journal:  Arthritis Res Ther       Date:  2010-07-05       Impact factor: 5.156

7.  Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts.

Authors:  Natalia Nacu; Irina G Luzina; Kendrick Highsmith; Virginia Lockatell; Kerill Pochetuhen; Zachary A Cooper; Michael P Gillmeister; Nevins W Todd; Sergei P Atamas
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

8.  Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage.

Authors:  F Ogawa; K Shimizu; T Hara; E Muroi; M Hasegawa; K Takehara; S Sato
Journal:  Clin Exp Rheumatol       Date:  2008 Jul-Aug       Impact factor: 4.473

9.  Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma.

Authors:  B W Needleman; F M Wigley; R W Stair
Journal:  Arthritis Rheum       Date:  1992-01

10.  Molecular subsets in the gene expression signatures of scleroderma skin.

Authors:  Ausra Milano; Sarah A Pendergrass; Jennifer L Sargent; Lacy K George; Timothy H McCalmont; M Kari Connolly; Michael L Whitfield
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more
  9 in total

Review 1.  Lactylation may be a Novel Posttranslational Modification in Inflammation in Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Yue Zhou; Li Yang; Xiaoying Liu; Hao Wang
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

2.  Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile.

Authors:  Brian Skaug; Dinesh Khanna; William R Swindell; Monique E Hinchcliff; Tracy M Frech; Virginia D Steen; Faye N Hant; Jessica K Gordon; Ami A Shah; Lisha Zhu; W Jim Zheng; Jeffrey L Browning; Alexander M S Barron; Minghua Wu; Sudha Visvanathan; Patrick Baum; Jennifer M Franks; Michael L Whitfield; Victoria K Shanmugam; Robyn T Domsic; Flavia V Castelino; Elana J Bernstein; Nancy Wareing; Marka A Lyons; Jun Ying; Julio Charles; Maureen D Mayes; Shervin Assassi
Journal:  Ann Rheum Dis       Date:  2019-11-25       Impact factor: 19.103

3.  Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma.

Authors:  Gyu-Tae Park; Jung-Won Yoon; Sang-Bin Yoo; Young-Chul Song; Parkyong Song; Hyoung-Kyu Kim; Jin Han; Sung-Jin Bae; Ki-Tae Ha; Natalia P Mishchenko; Sergey A Fedoreyev; Valentin A Stonik; Moon-Bum Kim; Jae-Ho Kim
Journal:  Mar Drugs       Date:  2021-04-23       Impact factor: 5.118

4.  Expansion of Fcγ Receptor IIIa-Positive Macrophages, Ficolin 1-Positive Monocyte-Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis.

Authors:  Dan Xue; Tracy Tabib; Christina Morse; Yi Yang; Robyn T Domsic; Dinesh Khanna; Robert Lafyatis
Journal:  Arthritis Rheumatol       Date:  2022-01-18       Impact factor: 10.995

5.  Inhibition of PDE4 by apremilast attenuates skin fibrosis through directly suppressing activation of M1 and T cells.

Authors:  Qiu-Kai Lu; Chen Fan; Cai-Gui Xiang; Bing Wu; Hui-Min Lu; Chun-Lan Feng; Xiao-Qian Yang; Heng Li; Wei Tang
Journal:  Acta Pharmacol Sin       Date:  2021-04-13       Impact factor: 7.169

Review 6.  Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights.

Authors:  Bingying Dai; Liqing Ding; Lijuan Zhao; Honglin Zhu; Hui Luo
Journal:  Front Pharmacol       Date:  2022-02-03       Impact factor: 5.810

7.  Fat transplantation induces dermal adipose regeneration and reverses skin fibrosis through dedifferentiation and redifferentiation of adipocytes.

Authors:  Jing Wang; Junrong Cai; Qian Zhang; Jiaqing Wen; Yunjun Liao; Feng Lu
Journal:  Stem Cell Res Ther       Date:  2022-10-09       Impact factor: 8.079

Review 8.  Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects.

Authors:  An-Na Chen; Yan Luo; Yu-Han Yang; Jian-Tao Fu; Xiu-Mei Geng; Jun-Ping Shi; Jin Yang
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

9.  PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis.

Authors:  Dan Xu; Swati Bhattacharyya; Wenxia Wang; Igal Ifergan; Ming-Yi Alice Chiang Wong; Daniele Procissi; Anjana Yeldandi; Swarna Bale; Roberta Goncalves Marangoni; Craig Horbinski; Stephen D Miller; John Varga
Journal:  JCI Insight       Date:  2022-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.